Intraosseous Infusion Device Market, By Product Type (FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, FASTx device, and NIO), By Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), By Route of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head of Humerus), By End-User (Hospitals, Emergency Medical Services, Ambulatory Surgical Centers, and Cardiac Care Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Intraosseous Infusion is a fast and effective way of getting critical fluids and medications into the vascular system. Whereas Intravenous (IV) access uses a peripheral vein, Intraosseous Infusion (IO) accesses the venous system through the bone marrow. Intraosseous Infusion can be done using various devices such as FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, Fastx Device, And NIO. Medication via vascular system is the most effective and fastest way for treating various diseases. There are three main locations for Intraosseous access, the humerus, the tibia and the sternum. For instance, In the 1990’s Pyng Medical introduced FAST1, the first easy-to-use, easy-to-learn, depth-controlled sternal IO device that was cleared by the US FDA and approved for military use. The FAST1 device has saved thousands of lives on the battlefield and in civilian communities by providing rapid and effective vascular access for all levels of health care providers. The global mice model market accounted for US$ 3.7 billion in 2020 and is estimated to be US$ 7.2 billion by 2029 and is anticipated to register a CAGR of 7.5%.

COVID-19 Impact on the Market:

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the production segment. Government across the countries has imposed strict lockdown to limit the spread of disease. However, increasing investments by prominent players and other industries has created growth opportunities, during this chaotic situation, to fulfill the demand of suppliers. This report will quantify the impact of this pandemic on the intraosseous infusion device market.

Increase in cardiovascular disease

According to WHO Cardiovascular diseases (CVDs) are the number one cause of death globally, taking an estimated 17.9 million lives each year. Four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.  With the increasing cases of cardiovascular diseases, the demand for the fastest and effective treatment is increasing which in-turn has increased the demand for the Intraosseous Infusion device. Therefore, boosting the market.

Rise in the number of trauma and emergency cases

Trauma and emergency cases are the major reasons for cardiovascular disease and death all over the world. Most of the time during such cases the patients does not have much time and require fast treatment. Intraosseous Infusion have been proven to be the most effective and adapted measure. Despite all the deaths, these emergency cases have been the driving factor for the global intraosseous infusion device market.

Restraints:

After effects of the intraosseous infusion

Intraosseous infusion is the process whereby the medicines are injected into the bone marrow, making the procedure very delicate. Intraosseous infusion device used for the procedure sometimes causes fracture due to the pressure of the device. It has also been observed that this procedure leads to infection or accidental leakage of the medication in the nearby unaffected tissues. These factors are responsible for the restraining of the market.

The global intraosseous infusion devicemarket is segmented based on the product type, technology, route of administration, end user, and region. 

Depending upon the product type, the global intraosseous infusion device market is categorized into FAST1 device, Dieckmann modified needle, BIG device, EZ-IO device, Jamshidi needle, FAST Responder, FASTx device, and NIO. Based on technology, the market is categorized into battery powered driver, manual IO needles, and impact driven devices. Based on route of administration, the market is segmented into distal femur, sternum, distal & proximal tibia, and calcaneus, and head of humerus. Based on end-users, the market is divided into hospitals, emergency medical ambulatory surgical centers, services, and cardiac care centers.

Regional insights:

Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, And Middle East & Africa. North America dominates the global intraosseous infusion device market in terms of revenue as compared to other regions. The market is boosting in this region due to increased cases of cardiovascular diseases, trauma, vascular related diseases. Further the advancement in the technology, availability of the product and the expert techniques and medical staff are driving the market. The second largest intraosseous infusion device market is in the Asia Pacific region.

Report scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the intraosseous infusion device market report based on the product type, technology, route of administration, end user, and region.

Global Intraosseous Infusion Device Market, By Product Type:

• FAST1 device
• Dieckmann Modified Needle
• BIG device
• EZ-IO device
• Jamshidi Needle
• FASTx device
• NIO

Global Intraosseous Infusion Device Market, By Technology :

• Battery Powered Driver
• Manual IO Needles
• Impact Driven Devices

Global Intraosseous Infusion Device Market, By Route of Administration :

• Distal Femur
• Sternum
• Distal & Proximal Tibia
• Calcaneus
• Head of Humerus

Global Intraosseous Infusion Device Market, By End Users :

• Hospitals
• Emergency Medical Ambulatory Surgical Centers
• Services
• Cardiac Care Centers

Global Intraosseous Infusion Device Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global intraosseous infusion device market include Pyng Medical Corp., Biopsybell, Cook Medical Incorporated, PAVmed, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson. Companies are increasing their investments in technology and supplies. For instance, On April 3, 2017, Teleflex Incorporated completed the acquisition of Pyng Medical, a medical device company that developed and marketed sternal intraosseous infusion products, which complements the Teleflex Incorporated’s anesthesia product portfolio. Further, on November, 2019, PAVmed Inc. announced that its groundbreaking PortIO Intraosseous Infusion System has achieved multiple important development, regulatory and intellectual property (IP) milestones towards establishing the first commercially available implantable intraosseous vascular access device.

• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• ACE Surgical Supply Company, Inc.
• Geistlich Pharma North America Inc.
• LifeNet Health
• RTI Surgical Holdings, Inc.
• BioHorizons, Inc.
• Dentsply Sirona Inc.
• Institut Straumann AG
• Citagenix, Inc.

 “*” marked represents similar segmentation in other categories in the respective section